KirkVShepardIIMD

Allergy & Immunology • Chicago, IL

Physician

Join to view full profile

Dr. Shepard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shepard's full profile

Already have an account?

Office
3000 N Halsted St
Ste 400
Chicago, IL 60657
Phone+1 773-296-5500

Fax+1 773-296-3800
Is this information wrong?

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2014 - 2017
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2014
University of South Florida MorsaniFellowship, Allergy and Immunology

Certifications & Licensure

IL State Medical License 2019 - 2026
OH State Medical License 1984 - 2022
FL State Medical License 2017 - 2021
WI State Medical License 2015 - 2017
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

6 citations
Life-Threatening Allergies: Using a Patient-Engaged Approach
Joel L. Gallagher, Robert Rivera, Kirk Van Shepard, Tanvir Roushan, Golam Mushih Tanimul Ahsan, Sheikh Iqbal Ahamed, Asriani Chiu, Mary Jurken, Pippa Simpson, Melodee ...> ;Telemedicine Journal and e-Health. 2019 Apr 17
Capsule Commentary on Peltz-Sinvani et al., Low ALT Levels Independently Associated with 22-Year All-Cause Mortality among Coronary Heart Disease Patients
Kirk Van Shepard> ;Journal of General Internal Medicine. 2016 Feb 1
1 citations
Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.
Kirk V. Shepard, Richard A. Larson, Michelle M. Le Beau, Lawrence Leichman, Bernard Levin> ;Investigational New Drugs. 1988 Jun 1
8 citations
Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma.
Kirk V. Shepard, Bernard Levin, Jack S. Faintuch, Manuel I. Doria, Ronnie A. DuBrow, Robert H. Riddell> ;American Journal of Clinical Oncology. 1987 Feb 1
51 citations
Liver pathology following hepatic arterial infusion chemotherapy: Hepatic toxicity with FUDR
Manuel I. Doria, Robert H. Riddell, Kirk V. Shepard, Bernard Levin> ;Cancer. 1986 Aug 15
10 citations
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
Kirk V. Shepard, Harvey M. Golomb, Jacob D. Bitran, Philip C. Hoffman, Steven B. Newman, Tom R. DeMeester, Consuelo Skosey> ;Cancer. 1985 Nov 15
2 citations
High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
Richard A. Larson, Ellen R. Gaynor, Kirk V. Shepard, Karen M. Daly> ;European Journal of Cancer & Clinical Oncology. 1985 Oct 1
63 citations
Intravenous etidronate in the management of malignant hypercalcemia
Elisabeth Ryzen, Raymond R. Martodam, Mark Troxell, Al B. Benson, Alexander H. G. Paterson, Kirk V. Shepard, Richard Hicks> ;Archives of Internal Medicine. 1985 Mar 1
80 citations
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.
Kirk V. Shepard, Bernard Levin, Richard C. Karl, Jack S. Faintuch, Ronnie A. DuBrow, Mary Hagle, Retha M. Cooper, Jan Beschorner, Donald M. Stablein> ;Journal of Clinical Oncology. 1985 Feb 1
Join now to see all

Press Mentions

Eisai Inc. Announces the Appointment of Dr. Andree Amelsberg as Vice President, U.S. Medical Affairs, Oncology Business GroupJune 28th, 2021
Eisai Inc. Announces the Appointment of Dr. Luca Dezzani as Vice President, U.S. Medical Affairs, Oncology Business GroupMay 20th, 2019